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patients, Gram-negative cover may need to be instituted
before more complete microbiological results can be
obtained, particularly since it has been shown that
Klebsiella chest infections are common in such
patients·,15 and that the outcome of bacteraemic
Klebsiella infections may be directly related [Q the early
institution of combined ~-lactam and aminoglycoside
therapy!
REFERENCES
1. Bulla A, Hiue KL. Acute respiratory infections: a review. Bull
World Healch Organ 1978; 56: 481-498.
2. Levison ME. The Pneumonias. Clinical Approaches co Infectious
Diseases of lhe Lower RespiralOry TraCE. Boston: John Wright PSG,
1984.
3. Seaton A, Seaton D, Leitch AG. Pneumonia. In: CroflOn and
Douglas's RespiralOry Diseases. 4th ed. Oxford: Blackwell Scientific
Foundation, 1989: 285-345.
4. Penningron JE. RespiralOry Infecriom: Diagnosis and Managelllem.
2nd ed. New York: Raven Press, 1989.
5. Bartlett JG, O'Keefe P, Tally FP, Louie TJ, Gorbach SL.
Bacteriology of hospital-acquired pneumonia. Arch Imem Med
1986; 146: 868-871.
6. De la Torre MG, Romero-Vivas J, Martinez-Belrran J, Guerrero
A, Meseguer M, Bouza E. Klebsiella bacteremia: an analysis of 100
episodes. Re-v Infecc Dis 1985; 7: 143-150.
7. Feldman C, Smith C, Kaka S, de Jong P. Analysis of rourine
sputum examination at Hillbrow Hospital. S Aft Med J 1992; 81:
42-43.
8. Feldman C, Kallenbach JM, Levy H, el al. Community-acquired
pneumonia of diverse aetiology: prognostic fearures in patients
admirred to an intensive care unit and a ;severirv of illness' score.
Imemive Care Med 1989; 15: 302-307. -
9. Feldman C, Smith C, Levy H, Ginsburg P, Miller SD, Koomhof
HI. Klebsiella pneumoniae bacteraemia at an urban general hospital.
J Infecc 1990; 20: 21-31.
10. Banlea JG. Diagnosis of bacterial infections of the lung. Clin Chesl
Med 1987; 8: 119-134.
11. Koneman EW, Alien SD, Dowell VR jun., Janda SD, Sommers
HM, \"(Tinn \"(TC jun. The Enterobacteriaciae. In: Colour Alias and
Texlbook of DiagnoSEic Microbiology. 3td ed. Philadelphia: JB
lippincoa, 1988: 89-156.
12. National Commiaee for Clinical Laboratory Standards (NCCLS).
Performance Swndards for Amimicrobial Disk SusceplibiliO' TeslS. 4th
ed. Document M2-A4, Vol. 10 No. 7.
13. Selker HP. Clinical prediction rules. N Engl J Med 1986; 314:
714-715.
14. Prout S, Potgieter PD, Forder AA, Moodie JW, Matthews I. ACUTe
community-acquired pneumonias. S Aft Med J 1983; 64: 443-446.
15. Potgieter PD, Harnmond JMJ. Etiology and diagnosis of pneumo-
nia requiring lCV admission. Chesl 1992; 101: 199-203.
16. Neu He. Advances in cephalosporin therapy: beyond the third
generdtion. Am J Med 1985; 79: suppl 2A.
17. Brun-Buisson C, Legrand P, Phillipon A, N10nrravers F, Ansequer
M, Duval J. Transferable e!1Z}matic resistance to.third-generation
cephalosporins during nosocomial ourbreak of multiresisranr
Klebsiella pneumoniae. LanCe! 1987; 2: 302-306.
Avascular necrosis ofbone following renal
transplantation
I. P. NAIKER, S. GOVENDER, S. NAICKER, S. DAWOOD,
A. A. HAFFEJEE, Y. K. SEEDAT
Abstract This study was undertaken to determine the inci-
dence and clinical features of avascular necrosis of
bone in 69 transplant recipients all of whOIn had a
functioning allograft for a least 12 months. An
attetnpt was also tnade to identifY any potential
predisposing factors. The patients were assessed
by an orthopaedic surgeon. The diagnosis of avas-
cular necrosis was tnade on the basis of radio-
graphs and isotope bone scans. Fourteen patients
(20,2%) developed avascular necrosis with a tnean
onset of 19 months post-transplantation.
The hip joint was most COIIlIIlOnly affected. The
isotope bone scan was the tnost sensitive diagnos-
tic tool; abnonnalities were detected before the
onset ofsym.ptotnS in 4 patients.
Avascular necrosis was more comtnon in
Indian transplant recipients and was also associa-
ted with: (z) cadaver transplants; (iz) more fre-
quent bouts of acute rejection (P < 0,05); and (iiz)
a greater incidence of other steroid-associated
side-effects (P < 0,05).
Alcohol conswnption and radiological evidence
ofosteoporosis were more prevalent in the avascu-
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lar necrosis group (42,8% v. 29,0% and 28,5% v.
7,2% respectively). Avascular necrosis did not cor-
relate with age, sex, renal function at 1 year or
severe secondary hyperparathyroidistn.
This study suggests that corticosteroid therapy
plays an itnportant role in the pathogenesis of
avascular necrosis. Excessive alcohol conswnption
and osteoporosis also appear to be risk facton;.
S AfT Med J 1993; 83: 646-649.
A
vascular necrosis of bone is most often associated
with conditions in which there is interruption of
the blood supply. It is most commonly encoun-
tered after traumatic disruption of the blood supply
associated with a fractured neck of the femur, slipped
femoral capital epiphysis or traumatic dislocation. I
Various disease states associated with arterial occlu-
sion such as atheromatous and embolic arterial disease,
neoplastic infiltration, inflammation associated with
osteomyelitis and sickle cell anaemia may also give rise
to the disorder. 1
The first association between corticosteroid therapy
and avascular necrosis was reported in 1957 in a patient
with pemphigus vulgaris who had received cortisone for
4 years. 2
In 1964 Starzl et aP first described the development
of avascular necrosis of the femoral head in 2 renal
transplant recipients. Since then avascular necrosis of
bone has become a well-recognised complication of
renal transplantation.
The pathogenesis of avascular necrosis in this setting





Diagnosis of avascular necrosis
Incidence and clinical features
Avascular necrosis was diagnosed in 14 of the 69
patients (20,2%). Onset of pain ranged from 2 months
to 36 months post-transplantation with the mean onset
at 19,1 months. A positive history was obtained in 10
patients, whereas clinical examination was abnormal in
only 4 patients (Table I). Radiographs demonstrated
avascular necrosis in 11 patients (78,5%); the isotope
bone scan was the most sensitive diagnostic tool, and
was positive in all of the patients in which it was done
(Table II). Two patients who underwent total hip
replacements several years before this study did not have
isotope bone scans; their diagnoses were made on clini-
cal and radiological grounds.
TABLE 11.
Clinical data correlations with avascular necrosis
Variables Present Absent
Age (yrs) 39,1 35,1 NS
Men/women 11/3 (78,5%) 38/17 (69%) NS
Organ source
(cadavers/LRD) 10/4 (71,4%) 28/27 (51%) r= 1,47
Bouts of acute
rejection/patient 1,08 0,58 P< 0,05
Dose methylpredni-
solone, 12 moo 8,56 mg 7,24 mg NS
Serum creatinine
(llmol/I), 12 moo 117±29,2 110 ± 35,2 NS
Steroid side-effects 0,85 0,34 P< 0,05















mal); (iiz) elevared parathyroid hormone levels; and (iv)
classic radiological features of osteitis fibrosa. Standard
immunosuppression consisted of 0,5 g intravenous
methylprednisolone sodium succinate (Solu-Medrol)
intra-operatively. This was followed by oral methylpred-
nisolone 32 mg/d for cadaver transplant recipients and
20 mg/d for living related transplant recipients. These
doses were gradually tapered to a maintenance dose by
12 months. Cyclosporin A was employed in a dose of 10
mg/kg/d in tWO divided doses and doses were adjusted
according to whole blood radio-immunoassay trough
levels. All patients barring those \vim an HlA-identical
march also received azathioprine 1 mg/kg/d.
Acute rejection was treated \vim intravenous methyl-
prednisolone sodium succinate 500 mg daily for a maxi-
mum of 5 days. Patients received either aluminium
hydroxide or calcium carbonate as phosphate binders.
Oral calcium preparations and vitamin D supplements
were utilised when necessary.
The statistical analysis of the data was performed by
means of Student's [-test. The probability attached to
differences bet\veen percentages was calculated by divi-
sion of the latter by their respective standard errors. A
probability ratio greater than 1,0 was regarded as signifi-
cant.
ing reports concerning the importance of several possi-
ble predisposing factors. The absolute dosage of corti-
costeroids,' steroid-induced metabolic disturbances such
as hyperlipidaemia,' osteoporosis; abnormal blood vis-
cosity and coagulability have all been implicated. Some
authors have suggested that secondary hyperparathy-
roidism plays an important role in the pathogenesis. 7
The incidence of avascular necrosis following renal
transplantation is unpredictable; reported incidences
range from 3% to 41 %.
The study was undertaken to determine the inci-
dence and clinical features of avascular necrosis in our
renal transplant population. An attempt was made to
identify any potential predisposing factors.
Patients and methods
We selected only those patients who had had a function-
ing allograft for a minimum period of 12 months.
Patients who had returned to dialysis, having lost their
allograft after 12 months, were excluded, as were
patients whose underlying renal disease required therapy
\vith corticosteroids, e.g. collagen vascular disease.
Sixty-nine patients (49 men, 20 women) were select-
ed, all of whom were interviewed and examined by an
orthopaedic surgeon. Radiographs of the pelvis and iso-
tope (methylene diphosphonate technetium-99) bone
scans were performed on all patients with the exception
of those in whom avascular necrosis had been diagnosed
before initiation of the study. Radiographs of other
joints were taken where indicated.
The diagnosis of avascular necrosis was based on
• radiological and/or radionuclide demonstration of bone
necrosis. The control group comprised patients who did
not have evidence of avascular necrosis. The diagnostic
sensitivity of symptoms and positive findings on clinical
examination were determined by review of the
orthopaedic assessment. All necessary clinical and bio-
chemical data were obtained from patient records.
Age at the time of transplantation, sex, race and
organ source were listed for all patients. The possibility
of a correlation between the occurrence of avascular
necrosis and the following factors was examined: (z)
number of bours of acure rejection; (iz) mean dose of
methylprednisolone (consumed by the patient at 12
months post-transplantation); (iiz) incidence of other
steroid-associated side-effects (cataracts, peptic ulcers
and corticosteroid-induced diabetes); (iv) severe sec-
ondary hyperparathyroidism; (v) obesity; (m) significant
alcohol intake; and (viz) radiological evidence of osteo-
porosis.
The prevalence of obesity was determined by refer-
ence to Fogany's table and alcohol consumption was
assessed by means of a specially designed questionnaire.
Significant alcohol consumption was defined as the
regular intake of a minimum of 10 drinks per week. A
drink was defined as: 1 can of beer (340 rnl), 1 glass of
wine (lOO rnl) or 1 measure of spirits (37,5 ml). The
following biochemical levels were recorded: serum crea-
tinine, cholesterol, triglycerides, calcium, phosphate and
alkaline phosphatase. Liver function tests (albumin,
globulin, bilirubin, gamma transpeptidase, alanine
aminotransferase and aspartate aminotransferase) were
done and parathyroid hormone levels assessed (where
indicated).
Mean values were calculated for each patient based
on post-transplantation measurements which were done
at 3, 6 and 12 months, and thereafter annually until
the time of the study. The following were regarded
as markers of severe secondary hyperparathyroidism: (z)
persistent hypercalcaemia; (iz) significantly elevated
alkaline phosphatase levels (> 2 x upper limit of nor-
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TABLE IV.
Correlation of race with avascular necrosis
Present No. %
Indian 11 32 25,6
Jr= 2,24
White 1 16 5,9
Coloured 2 1 66,6
Black 0 6 0
As expected the hip joint (femoral head) was most
frequently involved (13 patients); 1 patient had avascu-
lar necrosis of the knee and 1 patient had both hip and
ankle (talus) involvement. Avascular necrosis has been
reponed in the shoulder and elbow joints, i.e. humeral
head, distal humerus, proximal radius and ulna, 1 as well
as the venebrae, ribs, calcanea and metatarsal heads.'
Discussion
While it is apparent that avascular necrosis is an impor-
tant complication of renal transplantation, there is con-
siderable variability in the reponed incidence and the
pathogenesis remains controversial. The marked vari-
ability in the incidence of avascular necrosis following
renal transplantation has been attributed to differences
in the methods of evaluation, follow-up time before
analysis, and the relatively small number of patients in
some series."
Immunosuppressive regimens have also altered dra-
matically since the introduction of cyclosporin A. This
agent has made it possible for nephrologists to utilise
lower doses of corticosteroids as maintenance treaanent;
some centres advocate cyclosporin monotherapy as a
viable alternative.'o Furthermore the use of cyclosporin
A has also brought about a reduction in the cumulative
dose of steroids as a result of fewer rejection episodes in
the first 12 months following transplantation. '0
These cyc!osporin A low-dose steroid regimens have
been associated with a reduction in the incidence of
avascular necrosis of bone following renal transplanta-
tion!·l1,l2 Corticosteroid therapy appears to occupy a
central role in the pathogenesis of avascular necrosis
although the exact mechanism remains controversial.
One hypothesis is that corticosteroids, by enhancing
peripheral resistance to the action of insulin, elevate
insulin levels and stimulate the synthesis of very-low-
density lipoproteins. This accounts for the hypenrigly-
ceridaemia which develops post-transplantation but
does not explain the hypercholesterolaemia which also
occurs and which is rardy present while the patients are
on dialysis. Thus corticosteroid-induced hyperlipi-
daemia is thought to predispose to fany infiltration of
the liver' and subSequent ischaemic necrosis of bone
secondary to subchondral aneriolar Jat embolisation.'
Exogenous steroid therapy has also been linked to
the development of osteoporosis' consequent upon inhi-
bition of osteoblastic activity. Elmstedt13 supports the
hypothesis that avascular necrosis is due to microfrac-
tures in osteoporotic bone giving rise to local distur-
bance of the blood supply.
Excessive alcohol intake is another factor implicated
in the pathogenesis of avascular necrosis of bone and the
observations for the aforementioned two factors could
apply equally in this area. Subchondral arteriolar fat
emboli have been demonstrated in bones of alcoholics
presenting with avascular necrosis." Furthermore, alco-
hol is regarded as an impottant dietary risk factor for the
development of osteoporosis." The mechanisms
include a direct toxic effect on bone, alcohol-induced
calcium diuresis, poor nutritional status, hypogonadism
and reduced physical' activity.
Pre-existing or persistent hyperparathyroidism after
transplantation is regarded by some authors7 as playing
an important role in the pathogenesis of avascular
necrosis. It is speculated that increased bone resorption
combined with osteoporosis could lead to trabecular
collapse consequent upon weight bearing,' particularly
in the obese patient. The incidence of avascular necrosis
in our renal transplant patients was 20,2% which is well
within the reported range of 3 - 41 %. It has been reported
that most patients develop symptoms within 2 years of
transplantation.' Although the time of onset of pain in
our patients ranged from 2 months to 36 months post-
transplant, the mean onset was 19,1 ± 9,8 months. Joint
pain was present in 71,5% of our patients with avascular
necrosis whereas clinical examination was abnormal in
only 28,5%. This is not surprising as joint pain is the
presenting symptom in most cases and may precede the



















Clinical variables between the avascular necrosis and
control groups were compared and the findings are listed
in Table n. Mean age was similar in the two groups as
was the sex ratio. The apparent increased incidence in
men reflects the overall preponderance of men in our
transplant population. Avascular necrosis was associated
with cadaver transplants (71,4% v. 51 %), more frequent
bouts of acute rejection (1,08 per patient v. 0,58) and a
greater incidence of other steroid-associated side-effects
(0,85 per patient v. 0,34). The mean dose of methyl-
prednisolone and mean serum creatinine levels at 12
months post-transplantation did not differ significantly
between the two groups (8,56 v. 7,2 mg and 117 v. 110
).lll101/1 respectively).
The influence of alcohol consumption, pre-existing
osteoporosis and obesity is indicated in Table rn. Signi-
ficant alcohol consumption and radiological evidence of
osteoporosis were more prevalent in the avascular
necrosis group and the differences were statistically sig-
nificant.
Obesity was more prevalent in the control group;
this difference, however, did not attain statistical signi-
ficance. Both triglyceride (2,13 v. 1,9 ).lll1011l) and
cholesterol levels (6,70 v. 6,15 ).lll101) were higher in the
avascular necrosis group, but this difference was not sta-
tistically significant.
Severe secondary hyperparathyroidism occurred in a
minority of patients: 1/14 (7,1 %) in the avascular
necrosis group and 5/55 (9,0%) of the controls. Mean
calcium, phosphate, alkaline phosphatase and liver func-
tion tests were within the normal range in both groups
of patients.
Subdivision of patients according to race (Table IV)
demonstrates that the incidence of avascular necrosis
was significantly greater in Indians (25,6%) compared
with whites (5,9%). Avascular necrosis was present in 2
of the 3 coloured patients and did not occur in the 6
black patients. Statistical analysis of these two race
groups is not possible because of the small numbers
involved.
_------------------J- ~9
Four patients, however, were asymptomatic; the
diagnosis was made on the basis of an isotope bone
scan. Furthermore only I of these patients half an
abnormal radiograph; this underlines the high diagnostic
sensitivity of the isotope bone scan.
With regard to predisposing factors, we found that
avascular necrosis was more frequently observed in asso-
ciation with clldaver transplants and consequently with
more bouts of acute rejection. These differences were
statistically significant. This association suggests a
pathogenetic role for corticosteroids as cadaver trans-
plant recipients receive larger doses of oral cortico-
steroids and would also receive larger cumulative doses
of corticosteroids consequent upon the increased 'inci-
dence of acute rejection. Interestingly we also noted an
increased incidence of other steroid-associated side-
effects in the avascular necrosis group, which suggests
that these patients may have been unduly sensitive to
steroids. It is known that considerable individual vari-
ability exists in the propensity of renal transplant
patients to develop avascular necrosis. Avascular necro-
sis has been seen to develop in patients who experienced
no rejection episodes and who received relatively small
doses of corticosteroids, and yet did not develop in
patients who had many rejection episodes and who
received large doses of corticosteroids. I
Although our patients in the avascular necrosis group
experienced more bouts of acute rejection, the differ-
ence between the two groups as regards the mean corti-
costeroid dosage and mean serum creatinine levels at I
year post-transplant did not attain statistical signifi-
cance.
We found an association between significant alcohol
consumption, radiological evidence of osteoporosis and
the development of avascular necrosis. Severe secondary
hyperparathyroidism and hyperlipidaemia did not corre-
late with the development of avascular necrosis in this
study. evertheless the hypothesis that corticosteroid-
induced hyperlipidaemia gives rise to fatty irtfiltration of
the liver and subsequent arteriolar fat embolisation can-
not be entirely discounted by this study; lipid levels were
noted to be higher in the avascular necrosis group,
although this difference did not attain statistical signifi-
cance. Furthermore the normal liver function test results
observed in both groups of patients do not preclude the
possibility of hepatic fatty infiltration.
This study supports the hypothesis that cortico-
steroid-induced osteoporosis leads to avascular necrosis
secondary to the development of microfractures.
Although only 28,5% of the patients with avascular
necrosis had radiological evidence of osteoporosis, the
prevalence could well have been higher had bone been
examined histologically.
It was interesting to note the increased incidence of
avascular necrosis in our Indian transplant recipients.
The number of patients in our avascular necrosis group,
however, was too small to permit a meaningful inter-
racial comparison of potential risk factors so the reason
for this phenomenon remains obscure. A racial predis-
position has previously been reported by Patton er al.'
who found an increased incidence of avascular necrosis
in their black transplant recipients.
This study has demonstrated that most patients who
develop avascular necrosis following renal transplanta-
tion present with symptoms within 2 years. The isotope
bone scan was the most sensitive diagnostic tool and
was capable of detecting avascular necrosis even before
the development of symptoms. Regular isotope bone
scanning, however, is not recommended as definitive
surgical therapy would be inappropriate at such an early
stage in the development of avascular necrosis. This
study suggests that corticosteroid therapy plays an
important role in the pathogenesis of avascular necrosis
following renal transplantation. Excessive alcohol con-
sumption and radiological evidence of osteoporosis also
appear to be risk factors.
The trend towards triple-drug immunosuppressive
regimens or cyclosporin monotherapy should result in a
decline in the incidence of this complication.
We thank Miss E. de Wet for typing the manuscript.
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